InsurTech Investors & VC Firms in Global
188 firms in this list, with a median first check of $500K. 65 of them lead rounds. Generated from verified public data and updated continuously.
Jerusalem Venture Partners (JVP)
JerusalemSeed–Late Stage$1.5M – $43M
26 people
Propel Venture Partners
San FranciscoPre-Seed–Growth$500K – $5M
10 people
Suffolk Technologies
BostonSeed–Series B
16 people
SC Ventures
SingaporeSeed–Late Stage
21 people
Great Stuff Ventures
AmsterdamPre-Seed–Series A$50K – $108K
20 people
Iron Pillar
BangaloreSeed–Late Stage
26 people
Valar Ventures Llc
San FranciscoSeed–Series B$100K – $5M
10 people
Elevar Equity
BengaluruPre-Seed–Late Stage$1M – $10M
19 people
Edizione S.p.A.
Treviso
31 people
Global Insurance Accelerator
Des MoinesPre-Seed–Seed$50K
5 people
RSJ Investments SICAV a.s.
PrahaPre-Seed–Late Stage
28 people
Winning Together Fund
San FranciscoPre-Seed–Seed$25K – $50K
25 people
Zest
RomePre-Seed–Series A
25 people
Zigg Capital
New YorkSeed–Series C$4M
6 people
LVX Ventures
BangalorePre-Seed–Late Stage$179K – $10M
Creative Dock Group
Prague
27 people
Portage Ventures
MontrealPre-Seed–Late Stage
16 people
Yamaha Motor Ventures
Palo AltoSeed–Growth$1M – $3M
13 people
Sovereign Capital Partners
LondonGrowth
28 people
Anti
San JuanPre-Seed–Late Stage$250K – $30M
5 people
Rheingau Founders
BerlinPre-Seed–Late Stage$220K – $1.6M
9 people
Draft Ventures Llc
San FranciscoPre-Seed–Seed
4 people
PruVen Capital Partners
Los AltosSeed–Late Stage$100K – $10M
7 people
Eos Venture Partners Limited
LondonSeed–Series A$7M – $10M
16 people
Related lists
Investors & VC Firms in North America (13463)Investors & VC Firms in United States (12509)Investors & VC Firms in Europe (5824)Crypto & Web3 Investors & VC Firms (4943)Investors & VC Firms in Global (4734)AI & Machine Learning Investors & VC Firms (4509)Fintech Investors & VC Firms (4463)SaaS Investors & VC Firms (4201)Healthtech Investors & VC Firms (4103)Enterprise Software Investors & VC Firms (3934)
Data sourced from public filings and firms' own websites — see our methodology.































































































